Back to Newsroom

PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Translarna™ (ataluren) is now commercially available to patients in Germany, the first country to launch in the European Union (EU), with first shipments expected to begin this week.

Click here to read more